id-dh.bsky.social
@id-dh.bsky.social
Combined use of ibalizumab and lenacapavir for the treatment of multidrug-resistant HIV-1: A case series

✅ Just Accepted
🔗 https://bit.ly/47zMvQO
November 12, 2025 at 6:20 PM
November 3, 2025 at 5:25 PM
This directly relates to what we are currently learning in class! #PITT_IDFall25
Asymptomatic Tuberculosis in Children with Household Exposure to Mycobacterium tuberculosis

✅ Just Accepted
#IDSky
🔗 https://bit.ly/47csDBA
October 22, 2025 at 2:37 PM
A randomized phase 1 study investigating gut microbiome changes with moxifloxacin vs. oral vancomycin: Implications for Clostridioides difficile risk

✅ Just Accepted
#IDSky
🔗 https://bit.ly/47g3wy5
October 22, 2025 at 2:35 PM
October 14, 2025 at 2:23 PM
Respiratory Virus Infections and Pulmonary Impairment after Allogeneic Hematopoietic Cell Transplantation.

✅ Just Accepted
#IDSky
🔗 https://bit.ly/485qudb
October 8, 2025 at 11:04 PM
Investigating Azithromycin Activity Against ESBL-Producing Escherichia coli Under Physiologically Relevant Conditions

✅ Just Accepted
#IDSky

🔗 https://bit.ly/3KAnbAM
October 3, 2025 at 1:54 AM
Maternal Inflammation Likely Drives Impaired Immune Responses to Respiratory Syncytial Virus in HIV-Exposed Uninfected Infants

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3VzGVXR
October 3, 2025 at 1:53 AM
Disparate kinetics of viable virus shedding in immunocompromised patients: SARS-CoV-2 versus influenza virus ? a prospective real-world cohort study

✅ Just Accepted
#IDSky

🔗 https://bit.ly/48vcKbN
September 26, 2025 at 2:44 PM